BARAX
Price
$111.46
Change
-$1.31 (-1.16%)
Updated
Nov 14 closing price
PMAQX
Price
$47.96
Change
-$0.50 (-1.03%)
Updated
Nov 14 closing price
Ad is loading...

BARAX vs PMAQX

Header iconBARAX vs PMAQX Comparison
Open Charts BARAX vs PMAQXBanner chart's image
Baron Asset Retail
Price$111.46
Change-$1.31 (-1.16%)
VolumeN/A
CapitalizationN/A
Principal MidCap R6
Price$47.96
Change-$0.50 (-1.03%)
VolumeN/A
CapitalizationN/A
BARAX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BARAX vs. PMAQX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BARAX is a Buy and PMAQX is a Buy.

FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 30B vs. BARAX (4.32B). PMAQX pays higher dividends than BARAX: PMAQX (0.10) vs BARAX (0.00). BARAX was incepted earlier than PMAQX: BARAX (37 years) vs PMAQX (8 years). PMAQX is a more actively managed with annual turnover of: 10.10 vs. BARAX (5.48). PMAQX has a lower initial minimum investment than BARAX: PMAQX (0) vs BARAX (2000). PMAQX annual gain was more profitable for investors over the last year : 32.12 vs. BARAX (20.74). PMAQX return over 5 years is better than : 55.10 vs. BARAX (32.23).
BARAXPMAQXBARAX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence37 years8 years-
Gain YTD15.03626.39557%
Front LoadN/AN/A-
Min. Initial Investment20000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.32B30B14%
Annual Yield % from dividends0.000.10-
Returns for 1 year20.7432.1265%
Returns for 3 years-12.126.88-176%
Returns for 5 years32.2355.1058%
Returns for 10 years67.44N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIXT1.65-0.03
-1.79%
Lixte Biotechnology Holdings
ATRO16.49-0.38
-2.25%
Astronics Corp
LFST7.22-0.18
-2.43%
LifeStance Health Group
CVNA239.98-6.77
-2.74%
Carvana Co
IPSC1.33-0.08
-5.67%
Century Therapeutics